Literature DB >> 22133004

Temporal activation of β-catenin signaling in the chondrogenic process of mesenchymal stem cells affects the phenotype of the cartilage generated.

Zheng Yang1, Yu Zou, Xi Min Guo, Hwee San Tan, Vinitha Denslin, Chen Hua Yeow, Xia Fei Ren, Tong Ming Liu, James Hp Hui, Eng Hin Lee.   

Abstract

Adult mesenchymal stem cells (MSCs) are an attractive cell source for cartilage tissue engineering. In vitro predifferentiation of MSCs has been explored as a means to enhance MSC-based articular cartilage repair. However, there remain challenges to control and prevent the premature progression of MSC-derived chondrocytes to the hypertrophy. This study investigated the temporal effect of transforming growth factor (TGF)-β and β-catenin signaling co-activation during MSC chondrogenic differentiation and evaluated the influence of these predifferentiation conditions to subsequent phenotypic development of the cartilage. MSCs were differentiated in chondrogenic medium that contained either TGFβ alone, TGFβ with transient β-catenin coactivation, or TGFβ with continuous β-catenin coactivation. After in vitro differentiation, the pellets were transplanted into SCID mice. Both coactivation protocols resulted in the enhancement of chondrogenic differentiation of MSCs. Compared with TGFβ activation, transient coactivation of TGFβ-induction with β-catenin activation resulted in heightened hypertrophy and formed highly ossified tissues with marrow-like hematopoietic tissue in vivo. The continuous coactivation of the 2 signaling pathways, however, resulted in inhibition of progression to hypertrophy, marked by the suppression of type X collagen, Runx2, and alkaline phosphatase expression, and did not result in ossified tissue in vivo. Chondrocytes of the continuous co-activation samples secreted significantly more parathyroid hormone-related protein (PTHrP) and expressed cyclin D1. Our results suggest that temporal co-activation of the TGFβ signaling pathway with β-catenin can yield cartilage of different phenotype, represents a potential MSC predifferentiation protocol before clinical implantation, and has potential applications for the engineering of cartilage tissue.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22133004      PMCID: PMC3396140          DOI: 10.1089/scd.2011.0376

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  47 in total

1.  Wnt regulation of chondrocyte differentiation.

Authors:  Vicki Church; Tsutomu Nohno; Claudia Linker; Christophe Marcelle; Philippa Francis-West
Journal:  J Cell Sci       Date:  2002-12-15       Impact factor: 5.285

2.  Role of c-fos in the regulation of type X collagen gene expression by PTH and PTHrP: localization of a PTH/PTHrP-responsive region in the human COL10A1 enhancer.

Authors:  Silvia Riemer; Sonja Gebhard; Frank Beier; Ernst Pöschl; Klaus von der Mark
Journal:  J Cell Biochem       Date:  2002       Impact factor: 4.429

3.  Suppression of genes related to hypertrophy and osteogenesis in committed human mesenchymal stem cells cultured on novel nitrogen-rich plasma polymer coatings.

Authors:  Fackson Mwale; Pierre-Luc Girard-Lauriault; Hong Tian Wang; Sophie Lerouge; John Antoniou; Michael R Wertheimer
Journal:  Tissue Eng       Date:  2006-09

4.  Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor.

Authors:  Yu-Feng Dong; Do Y Soung; Edward M Schwarz; Regis J O'Keefe; Hicham Drissi
Journal:  J Cell Physiol       Date:  2006-07       Impact factor: 6.384

5.  Transforming growth factor-beta stimulates cyclin D1 expression through activation of beta-catenin signaling in chondrocytes.

Authors:  Tian-Fang Li; Di Chen; Qiuqian Wu; Mo Chen; Tzong-Jen Sheu; Edward M Schwarz; Hicham Drissi; Michael Zuscik; Regis J O'Keefe
Journal:  J Biol Chem       Date:  2006-05-10       Impact factor: 5.157

6.  Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice.

Authors:  Karoliina Pelttari; Anja Winter; Eric Steck; Katrin Goetzke; Thea Hennig; Bjoern Gunnar Ochs; Thomas Aigner; Wiltrud Richter
Journal:  Arthritis Rheum       Date:  2006-10

7.  Failure of in vitro-differentiated mesenchymal stem cells from the synovial membrane to form ectopic stable cartilage in vivo.

Authors:  Cosimo De Bari; Francesco Dell'Accio; Frank P Luyten
Journal:  Arthritis Rheum       Date:  2004-01

8.  Wnt-3A enhances bone morphogenetic protein-2-mediated chondrogenesis of murine C3H10T1/2 mesenchymal cells.

Authors:  Leslie Fischer; Genevieve Boland; Rocky S Tuan
Journal:  J Biol Chem       Date:  2002-06-20       Impact factor: 5.157

9.  Transforming growth factor-beta-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogen-activated protein kinase and Wnt signaling cross-talk.

Authors:  Richard Tuli; Suraj Tuli; Sumon Nandi; Xiaoxue Huang; Paul A Manner; William J Hozack; Keith G Danielson; David J Hall; Rocky S Tuan
Journal:  J Biol Chem       Date:  2003-07-31       Impact factor: 5.157

10.  Dual roles of Wnt signaling during chondrogenesis in the chicken limb.

Authors:  C Hartmann; C J Tabin
Journal:  Development       Date:  2000-07       Impact factor: 6.868

View more
  13 in total

Review 1.  Towards Three-Dimensional Dynamic Regulation and In Situ Characterization of Single Stem Cell Phenotype Using Microfluidics.

Authors:  Sébastien Sart; Spiros N Agathos
Journal:  Mol Biotechnol       Date:  2018-11       Impact factor: 2.695

Review 2.  WNT Signalling in Osteoarthritis and Its Pharmacological Targeting.

Authors:  Anna De Palma; Giovanna Nalesso
Journal:  Handb Exp Pharmacol       Date:  2021

Review 3.  Chondrogenic differentiation of amniotic fluid stem cells and their potential for regenerative therapy.

Authors:  Andrea Preitschopf; Hannes Zwickl; Kongzhao Li; Gert Lubec; Gabor Joo; Margit Rosner; Markus Hengstschläger; Mario Mikula
Journal:  Stem Cell Rev Rep       Date:  2012-12       Impact factor: 5.739

4.  Exogenous activation of Wnt/β-catenin signaling attenuates binge alcohol-induced deficient bone fracture healing.

Authors:  Kristen L Lauing; Sumana Sundaramurthy; Rachel K Nauer; John J Callaci
Journal:  Alcohol Alcohol       Date:  2014-03-13       Impact factor: 2.826

5.  Electrospun gelatin/polycaprolactone nanofibrous membranes combined with a coculture of bone marrow stromal cells and chondrocytes for cartilage engineering.

Authors:  Xiaomin He; Bei Feng; Chuanpei Huang; Hao Wang; Yang Ge; Renjie Hu; Meng Yin; Zhiwei Xu; Wei Wang; Wei Fu; Jinghao Zheng
Journal:  Int J Nanomedicine       Date:  2015-03-17

6.  Enhanced Chondrogenic Differentiation of Human Umbilical Cord Wharton's Jelly Derived Mesenchymal Stem Cells by GSK-3 Inhibitors.

Authors:  Prapot Tanthaisong; Sumeth Imsoonthornruksa; Apichart Ngernsoungnern; Piyada Ngernsoungnern; Mariena Ketudat-Cairns; Rangsun Parnpai
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

Review 7.  Wnt signaling: a promising target for osteoarthritis therapy.

Authors:  Yudan Wang; Xinhao Fan; Lei Xing; Faming Tian
Journal:  Cell Commun Signal       Date:  2019-08-16       Impact factor: 5.712

8.  A single day of TGF-β1 exposure activates chondrogenic and hypertrophic differentiation pathways in bone marrow-derived stromal cells.

Authors:  Kathryn Futrega; Pamela G Robey; Travis J Klein; Ross W Crawford; Michael R Doran
Journal:  Commun Biol       Date:  2021-01-04

Review 9.  The Regulatory Role of Signaling Crosstalk in Hypertrophy of MSCs and Human Articular Chondrocytes.

Authors:  Leilei Zhong; Xiaobin Huang; Marcel Karperien; Janine N Post
Journal:  Int J Mol Sci       Date:  2015-08-14       Impact factor: 5.923

Review 10.  Cellular senescence in aging and osteoarthritis.

Authors:  Wei Seong Toh; Mats Brittberg; Jack Farr; Casper Bindzus Foldager; Andreas H Gomoll; James Hoi Po Hui; James B Richardson; Sally Roberts; Myron Spector
Journal:  Acta Orthop       Date:  2016-09-23       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.